Inventor · disambiguated record
Alison Jo-Anne Woolford
Also filed as: WOOLFORD ALISON J · WOOLFORD ALISON JO-ANNE
29 granted patents·17 pending applications·225 citations·filing 2003–2023
97Inventor score
Files withASTEX THERAPEUTICS LTD18GLAXOSMITHKLINE IP DEV LTD11CHESSARI GIANNI4OTSUKA PHARMA CO LTD4BERDINI VALERIO2
Top patents by PatentIndex Score
46 records- 0195US9458158B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2015·Granted Oct 4, 2016·11 cites·22 claims
- 0295US7385059B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2006·Granted Jun 10, 2008·33 cites·20 claims
- 0394US7700625B2Hydroxybenzamide derivatives and their use as inhibitors of Hsp90ASTEX THERAPEUTICS LTD·Filed 2007·Granted Apr 20, 2010·25 cites·10 claims
- 0492US11866428B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2020·Granted Jan 9, 2024·2 cites·21 claims
- 0592US11001575B1Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2019·Granted May 11, 2021·4 cites·26 claims
- 0692US8101648B2Hydroxybenzamide derivatives and their use as inhibitors of HSP90CHESSARI GIANNI·Filed 2006·Granted Jan 24, 2012·20 cites·18 claims
- 0791US10457669B2Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2016·Granted Oct 29, 2019·5 cites·25 claims
- 0890US10485806B2Nrf2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Nov 26, 2019·3 cites·10 claims
- 0990US9676768B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2015·Granted Jun 13, 2017·8 cites·16 claims
- 1090US9155743B2Bicyclic heterocycle compounds and their uses in therapyBUCK ILDIKO MARIA·Filed 2012·Granted Oct 13, 2015·12 cites·18 claims
- 1190US7977477B2Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2004·Granted Jul 12, 2011·35 cites·23 claims
- 1289US8530469B2Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90CHESSARI GIANNI·Filed 2011·Granted Sep 10, 2013·11 cites·21 claims
- 1388US10272095B2NRF2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Apr 30, 2019·4 cites·18 claims
- 1488US7825140B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2007·Granted Nov 2, 2010·7 cites·19 claims
- 1588US7745638B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2007·Granted Jun 29, 2010·8 cites·23 claims
- 1687US9018214B2Bicyclic heterocycle compounds and their uses in therapyWOOLFORD ALISON JO-ANNE·Filed 2012·Granted Apr 28, 2015·13 cites·21 claims
- 1785US8080666B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsBERDINI VALERIO·Filed 2010·Granted Dec 20, 2011·6 cites·19 claims
- 1885US2024199607A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1982US10604509B2Nrf2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Mar 31, 2020·2 cites·26 claims
- 2082US2024368136A1Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 2178US8816087B2Hydroxybenzamide derivatives and their use as inhibitors of Hsp90CHESSARI GIANNI·Filed 2007·Granted Aug 26, 2014·2 cites·15 claims
- 2277US10364256B2Biaryl pyrazoles as NRF2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 30, 2019·2 cites·15 claims
- 2377US8779147B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsBERDINI VALERIO·Filed 2011·Granted Jul 15, 2014·2 cites·14 claims
- 2477US8653084B2Hydrobenzamide derivatives as inhibitors of Hsp90FREDERICKSON MARTYN·Filed 2007·Granted Feb 18, 2014·5 cites·9 claims
- 2575US10144731B2Nrf2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Dec 4, 2018·2 cites·12 claims
- 2675US9428439B2Hydrobenzamide derivatives as inhibitors of Hsp90ASTEX THERAPEUTICS LTD·Filed 2014·Granted Aug 30, 2016·2 cites·11 claims
- 2772US11939321B2Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2021·Granted Mar 26, 2024·0 cites·28 claims
- 2869US2023047296A1Nrf2 REGULATORSGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Application pending·0 cites
- 2967US2019375748A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 3066US9914719B2Hydroxybenzamide derivatives and their use as inhibitors of HSP90ASTEX THERAPEUTICS LTD·Filed 2014·Granted Mar 13, 2018·0 cites·21 claims
- 3165US9051278B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Jun 9, 2015·0 cites·24 claims
- 3263US8598217B2Imidazole derivatives and their use as modulators of cyclin dependent kinasesHOWARD STEVEN·Filed 2010·Granted Dec 3, 2013·1 cites·18 claims
- 3361US2017334907A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 3458US2020079759A1Nrf2 REGULATORSGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Application pending·0 cites
- 3555US2014010892A1Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2013·Application pending·0 cites
- 3654US2010216782A1Hydroxybenzamide derivatives and their use as inhibitors of hsp90CHESSARI GIANNI·Filed 2010·Application pending·0 cites
- 3751US2011224203A1Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2011·Application pending·0 cites
- 3850US2019002454A1NRF2 RegulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 3947US2009215777A1Pyrimidine Derivatives As HSP90 InhibitorsASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 4045US2006135589A11h-Indazole-3-carboxamide compounds as cyclin dependent kinase (cdk) inhibitorsASTEX TECHNOLOGY INC·Filed 2003·Application pending·0 cites
- 4143US2010160324A1Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinasesASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 4243US2006135516A13-(Carbonyl) 1h-indazole compounds as cyclin dependent kinases (cdk) inhibitorsASTEX TECHNOLOGY LTD·Filed 2003·Application pending·0 cites
- 4341US2020071310A1N-aryl pyrazoles as nrf2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 4439US2020031820A13-carboxylic acid pyrroles as nrf2 regulatorsGLSXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD·Filed 2017·Application pending·0 cites
- 4537US10351530B2Arylcyclohexyl pyrazoles as NRF2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 16, 2019·0 cites·8 claims
- 4637US2018179167A1Nrf2 REGULATORSGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →